Valuation Pacira BioSciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-14 pm EST			5-day change	1st Jan Change
22.24 ^USD	+2.96%		-14.46%	-14.06%

Jan. 14	Pacira BioSciences, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 11:15 AM
Jan. 13	Pacira BioSciences Partners With LG Chem to Sell Post-Surgical Pain Medication in Certain Asia-Pacific Markets	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	2,600	2,680	1,772	1,567	869.9	956.8	956.8	-
Change	-	3.1%	-33.9%	-11.56%	-44.48%	9.99%	0%	-
Enterprise Value (EV) ¹	2,962	3,144	2,357	1,811	970.6	1,087	1,119	923.3
Change	-	6.13%	-25.03%	-23.17%	-46.39%	12.01%	2.92%	-17.49%
P/E ratio	18x	65.4x	114x	37.9x	-8.76x	38.7x	12.7x	8.79x
PBR	4.21x	3.69x	2.29x	-	1.12x	1.44x	1.3x	1x
PEG	-	-0.9x	-1.8x	0x	0x	-0x	0x	0.2x
Capitalization / Revenue	6.05x	4.95x	2.66x	2.32x	1.24x	1.31x	1.21x	1.1x
EV / Revenue	6.89x	5.81x	3.53x	2.68x	1.38x	1.49x	1.41x	1.06x
EV / EBITDA	26.3x	15.4x	11.1x	8.44x	4.34x	5.34x	5.1x	3.86x
EV / EBIT	29.8x	16.6x	12.1x	9.16x	4.77x	6.11x	6.02x	4.5x
EV / FCF	40.6x	39.4x	20.5x	13x	5.43x	8.21x	6.93x	4.49x
FCF Yield	2.47%	2.54%	4.89%	7.7%	18.4%	12.2%	14.4%	22.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	3.33	0.92	0.34	0.89	-2.15	0.575	1.745	2.53
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	429.6	541.5	666.8	675	701	731.6	792.2	870.6
EBITDA ¹	112.6	204	212.7	214.5	223.9	203.6	219.3	239
EBIT ¹	99.3	189.2	194.8	197.7	203.3	178	185.8	205.2
Net income ¹	145.5	41.98	15.91	41.96	-99.56	25.41	77.23	99.72
Net Debt ¹	362.7	463.7	585.3	243.9	100.7	130.4	162.2	-33.5
Reference price ²	59.84	60.17	38.61	33.74	18.84	22.24	22.24	22.24
Nbr of stocks (in thousands)	43,444	44,544	45,882	46,438	46,173	43,021	43,021	-
Announcement Date	2/25/21	2/24/22	2/28/23	2/29/24	2/27/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PACIRA BIOSCIENCES, INC.	37.57x	1.45x	5.2x	-	929M
ELI LILLY AND COMPANY	47.06x	15.58x	34.57x	0.55%	964B
JOHNSON & JOHNSON	20.75x	5.76x	16.04x	2.42%	515B
ABBVIE INC.	74.8x	7.32x	17.57x	2.96%	390B
ROCHE HOLDING AG	19.82x	4.95x	12.32x	2.9%	363B
ASTRAZENECA PLC	28.42x	5.34x	15.85x	1.72%	292B
NOVARTIS AG	19.88x	5.26x	12.34x	2.88%	272B
MERCK & CO., INC.	13.91x	4.55x	9.79x	2.99%	269B
NOVO NORDISK A/S	16.61x	5.87x	12.14x	3.04%	265B
AMGEN INC.	25.37x	6.03x	10.33x	2.95%	175B
Average	30.42x	6.21x	14.61x	2.49%	350.6B
Weighted average by Cap.	33.88x	8.41x	19.56x	2.11%